Research To Practice | Oncology Videos

Featuring perspectives from Drs Ghassan Abou‑Alfa and Richard S Finn, including the following topics: Introduction (0:00) Prologue: Last Week (2:33) Hepatocellular Carcinoma (4:37) Biliary Tract Cancers (35:20) CME information and select publications

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hepatobiliary Cancers — Facutly Presentation 1: Hepatocellular Carcinoma — Dr Ghassan Abou-Alfa CME information and select publications

Featuring perspectives from Ms Jamie Carroll, Dr Virginia Kaklamani, Dr Joyce O'Shaughnessy and Mr Ronald Stein, including the following topics: Introduction (0:00) ER-Positive, HER2-Negative Localized Breast Cancer — Part 1 (7:12) ER-Positive, HER2-Negative Localized Breast Cancer —Part 2 (26:18) ER-Positive Metastatic Breast Cancer (37:16) Localized HER2-Positive Breast Cancer (49:27) HER2-Positive and HER2-Low Metastatic Breast Cancer — Part 1 (1:04:09) HER2-Positive and HER2-Low Metastatic Breast Cancer — Part 2 (1:27:00) PARP Inhibitors (1:32:21) Immune Checkpoint Inhibitors (1:43:32) CME information and select publications

Featuring perspectives from Ms Paula J Anastasia, Dr Michael J Birrer, Ms Jennifer Filipi and Dr Brian M Slomovitz, including the following topics: Introduction (0:00) Overview of Endometrial Cancer (9:50) Management of Microsatellite Instability-High Endometrial Cancer (23:40) Management of Microsatellite-Stable Endometrial Cancer (33:32) Clinical Trials in Endometrial Cancer (50:04) Systemic Therapy for Cervical Cancer — Immunotherapy (1:03:44) Antibody-Drug Conjugates for Cervical Cancer — Tisotumab Vedotin (1:16:01) NCPD information and select publications

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer Faculty Presentation 2: Other Therapeutic Considerations in CRC — Dr Pashtoon M Kasi CME information and select publications

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer Faculty Presentation 1: Targeted Therapy for Colorectal Cancer (CRC) — Dr Wells A Messersmith CME information and select publications

Featuring perspectives from Drs Pashtoon M Kasi and Wells A Messersmith, including the following topics: Introduction (0:00) Overview of Endometrial Cancer (9:50) Management of Microsatellite Instability-High Endometrial Cancer (23:40) Management of Microsatellite-Stable Endometrial Cancer (33:32) Clinical Trials in Endometrial Cancer (50:04) Systemic Therapy for Cervical Cancer — Immunotherapy (1:03:44) Antibody-Drug Conjugates for Cervical Cancer — Tisotumab Vedotin (1:16:01) CME information and select publications

Featuring perspectives from Drs Andrew J Armstrong and Rana R McKay, including the following topics: Introduction (0:00) Intensification of endocrine therapy: Emerging role in nonmetastatic disease; choice of androgen deprivation therapy (3:31) Management of castration-resistant M0 disease; PROTACs, CDK4/6 inhibitors and other new endocrine approaches (16:18) Hormone-sensitive metastatic disease — Choice of antiandrogen (26:48) Castration-resistant metastatic disease (37:06) Genomic evaluation; PARP inhibitors for metastatic disease (46:24) Ideal sequencing of PARP inhibitors; management of associated side effects (55:21) Biomarker testing; MSI-high disease; TKIs with immunotherapy; bispecific antibodies? (59:42) CME information and select publications

Oncology Today: Recent Research Advances in Prostate Cancer and the Clinical Implications – A 2023 Post-ASCO GU Activity — Faculty Presentation: Dr Daniel Petrylak Visit our website for more publications

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer — Faculty Presentation 2: Advances in the Care of Patients with Nonmetastatic NSCLC and Small Cell Lung Cancer — Dr Luis Paz-Ares CME information and select publications